« Big Ministry Meeting: Why are India Pharma Groups Selling to MNCs? | Main | Comparative Value Proof - New Drugs, Biosimilars & Generics »

05/28/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013482645f7a970c

Listed below are links to weblogs that reference EU approvals for Amgen’s drug Prolia (denosumab):

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

The FDA follows suit and give Prolia early approval. Go Dmab!
http://blogs.forbes.com/sciencebiz/2010/06/amgen-bone-drug-gets-fda-nod/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada